Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Reunion Health News.
Press releases published on August 20, 2025
BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health
GlobeNewswire
·
August 20, 2025
BURLINGTON, Mass. and JERUSALEM, Aug. 20, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ …
TerrAscend Announces Renewal and Replenishment of $10 Million Share Repurchase Program
GlobeNewswire
·
August 20, 2025
TORONTO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that its Board of Directors has authorized the Company to renew and replenish …
Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer’s Disease
GlobeNewswire
·
August 20, 2025
Pre-Treatment with blarcamesine entirely prevented Abeta-induced cognitive decline Confirmed significant biomarker-response in hippocampus NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a …
Rezolute Appoints Seasoned Commercial Executive Sunil Karnawat as Chief Commercial Officer
GlobeNewswire
·
August 20, 2025
REDWOOD CITY, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism (HI), today announced the appointment of Sunil …
MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 20, 2025
YAVNE, Israel, August 20, 2025 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that Ofer Gonen, Chief Executive Officer, will participate in a fireside chat, hosted by …
Cytokinetics Names Jim Daly to Board of Directors
GlobeNewswire
·
August 20, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the appointment of James M. Daly to its Board of Directors effective August 19, 2025. Mr. Daly brings over 30 years of global …
Genome Editing Market to Grow at 16.9% CAGR Through 2030
GlobeNewswire
·
August 20, 2025
Boston, Aug. 20, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Genome Editing: Technologies and Global Markets” is projected to grow from $10.8 billion in 2025 to $23.7 billion by the end of 2030, at a compound annual …
First PRIZM Study Participant Enrolled in Tisento Therapeutics’ Open-Label Extension Study in MELAS
GlobeNewswire
·
August 20, 2025
CAMBRIDGE, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Tisento Therapeutics today announced that the first participant has enrolled in the company’s open-label extension study in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like …
Iantrek Raises $42 Million Series C to Launch AlloFlo™ Uveo, a Breakthrough Interventional Glaucoma Therapy
GlobeNewswire
·
August 20, 2025
WHITE PLAINS, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Iantrek, Inc., a pioneer in bio-interventional ophthalmic surgery (BIOS), today announced the close of a $42 million Series C financing round, which will fund the U.S. commercial launch of AlloFlo™ Uveo …
I-Mab Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 20, 2025
Positive givastomig Phase 1b dose escalation data in combination with immunochemotherapy in patients with 1L gastric cancers presented at ESMO GI 2025 showing 83% ORR at doses selected for ongoing expansion study Topline data from planned dose expansion …
Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference
GlobeNewswire
·
August 20, 2025
DEER PARK, Ill., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members …
Global Hearing Aids Market to Surpass USD 14.42 Billion by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 20, 2025
Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Growing Prevalence of Hearing Loss and Smart Technology Adoption Fuel Sector Expansion The global hearing aids market, valued at US$9.74 billion in 2024, stood at US$10.35 billion in 2025 and is projected …
Sai Life Sciences secures SBTi validation for near-term climate targets
GlobeNewswire
·
August 20, 2025
HYDERABAD, India, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused Contract Research, Development, and Manufacturing Organization (CRDMO), announced that its near-term targets to cut greenhouse …
Healthletic Reports 91% of Users Experience Noticeable Energy Boost with USP-Grade Methylene Blue Formula
GlobeNewswire
·
August 20, 2025
Texas, USA, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Healthletic, a premier U.S.-based wellness supplement manufacturer, today released comprehensive user outcome data revealing that 91% of customers using its Ultimate Methylene Blue drops reported experiencing a …
HUTCHMED Completes Patient Enrollment of SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in China
GlobeNewswire
·
August 20, 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces the completion of patient enrollment of SANOVO, a China Phase III study of ORPATHYS® ( …